-
Non-coding mutations reveal cancer driver cistromes in luminal breast cancer
Study
EGAS00001005235
-
Sequencing of an adolescent patient with germline RET mutant alveolar rhabdomyosarcoma
Study
EGAS00001004359
-
TP53 variant detection analysis in high grade serous epithelial ovarian cancer
Study
EGAS00001004361
-
Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection
Study
EGAS00001003206
-
SPECTA RP-1759-AYA Sarcoma cohort
Study
EGAS00001005840
-
Epigenetic analyses of methylation and nucleosome occupancy in cell-free DNA (cfNOMe)
Study
EGAS00001004370
-
Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis
Study
EGAS00001004373
-
Temporal stability of circulating microRNAs in human serum
Study
EGAS00001003221
-
Genomic landscape of oral cancers (Illumina WGS)
Study
EGAS00001003228
-
Functional Mapping of AKT Signaling and Biomarkers of Response From the FAIRLANE Trial of Neoadjuvant Ipatasertib Plus Paclitaxel for Triple-Negative Breast Cancer
Study
EGAS00001005892
-
Subtype specific studies of breast cancer progression. Milan cohort.
Study
EGAS00001004390
-
Intratumoural heterogeneity and immune modulation in lung adenocarcinoma of female smokers and never smokers
Study
EGAS00001006331
-
Nucleosome footprinting in plasma cell-free DNA for diagnosis of ovarian cancer
Study
EGAS00001005361
-
Discovery of new fusion transcripts in a cohort of pediatric solid cancers at relapse
Study
EGAS00001003236
-
Personalised Mapping of Tumour Development in Synchronous Colorectal Cancer Patients
Study
EGAS00001004413
-
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
Study
EGAS00001004405
-
Fibroblast heterogeneity drives metastatic spread in breast cancer through distinct mechanisms
Study
EGAS00001003238
-
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
Study
EGAS00001004406
-
Dual-mTOR inhibitor Rapalink-1 reduces prostate cancer patient-derived xenograft growth and alters tumor heterogeneity
Study
EGAS00001004431
-
Patient-derived organoids as a novel tool to study cervical cancer
Study
EGAS00001004439
-
Pediatric Papillary Thyroid Carcinoma RNA-Seq
Study
EGAS00001005182
-
Single-cell analysis for metastatic gastric adenocarcinoma
Study
EGAS00001004443
-
Somatic_mutation_profiling_of_intestinal_crypts_from_IBD_Full_STDY
Study
EGAS00001003249
-
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Study
EGAS00001004445
-
Single cell genomic variation induced by mutational processes in cancer
Study
EGAS00001006343
-
Genomic characterization of co-existing biliary tract intraepithelial neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer
Study
EGAS00001005402
-
Identifying transcriptional programs underlying anti-EGFR small molecule response and resistance with TraCe-seq
Study
EGAS00001005405
-
scRNA-seq of HGSC tumor and ascites
Study
EGAS00001004829
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Breast cohort
Study
EGAS00001004446
-
Genotyping by OncoArray and Global Screening Array for colorectal cancer risk prediction
Study
EGAS00001005411
-
NSCCG CRC GWAS data
Study
EGAS00001005412
-
Custom long non-coding RNA capture enhances detection sensitivity in different human sample types.
Study
EGAS00001005418
-
Mutational_burden_in_human_hair_follicles
Study
EGAS00001004462
-
Single cell RNA sequencing of normal endometrial derived organoids uncovers novel cell type markers for prognostication
Study
EGAS00001004466
-
COIN CRC GWAS data
Study
EGAS00001005421
-
Evolutionary analysis of pancreatic neoplastic cysts through whole-exome and targeted sequencing
Study
EGAS00001004473
-
ANGIOPREDICT - an FP7-funded project enabling personalised medicine for patients with metastatic colorectal cancer.
Study
EGAS00001005423
-
Chromothripsis followed by circular recombination drives oncogene amplification in human cancer
Study
EGAS00001005424
-
Combined targeting of BRD4-associated Promoter Activation and NFKB Immunomodulation in ARID1A-mutated Gastric Adenocarcinoma
Study
EGAS00001006397
-
A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients
Study
EGAS00001004491
-
Genome analysis of early onset sporadic rectal cancer
Study
EGAS00001005970
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-5)
Study
EGAS00001006114
-
Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer; a post-hoc analysis of the randomized controlled trial AGITG-MAX
Study
EGAS00001005453
-
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis
Study
EGAS00001005982
-
Transcriptome sequencing of Gingivo-buccal Cancer : ICGC-India Project_Batch05
Study
EGAS00001003285
-
RNA sequencing of undifferentiated sarcomas
Study
EGAS00001003291
-
Whole genome sequencing of tumour and matched normal from patients with family history of breast cancer
Study
EGAS00001003305
-
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Study
EGAS00001006004
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
Non-small cell lung cancer proteome subtypes expose targetable oncogenic drivers and immune evasion mechanisms
Study
EGAS00001005482